Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04978168 · ClinicalTrials.gov registry record · NA
Opioid Treatment and Peer Recovery Support
A NA study of Opioid Use Disorder, sponsored by Brown University.
- Recruiting
- Registry status
- NA
- Development phase
- 450
- Enrollment target
- 3
- Study locations
NCT04978168: Recruiting NA study of Opioid Use Disorder, sponsored by Brown University.
NCT04978168 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Brown University. The registered enrollment target is 450 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (90% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04978168, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Brown University.
- RECRUITING
- Registry status
- NA
- Development phase
- 450 participants
- Enrollment target
- 3
- Study locations
Study Summary
Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.
Primary Outcome
Calculated from self-report survey of being enrolled in MOUD (yes or no) at each assessment.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual (TAU)
- BEHAVIORAL Core Intervention
- BEHAVIORAL Peer Support Specialists (PSS)
Study Locations (3)
North Carolina
- Duke University - Durham
Pennsylvania
- Temple University - Philadelphia
Rhode Island
- Brown University - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2021-03-02 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT04978168 shows while recruiting
NCT04978168 is an interventional study that assigns participants to a tested intervention. The registered 450 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 3 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT04978168 reports a single indexed study location in North Carolina, Pennsylvania, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT04978168 about?
NCT04978168 is a clinical study titled "Opioid Treatment and Peer Recovery Support". Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by t...
What is the current status of trial NCT04978168?
This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2021-03-02. Estimated completion is 2026-04-30.
What conditions does trial NCT04978168 study?
This clinical trial studies the following conditions: Opioid Use Disorder.
What interventions are being tested in trial NCT04978168?
The interventions under investigation include: Treatment as Usual (TAU) (BEHAVIORAL), Core Intervention (BEHAVIORAL), Peer Support Specialists (PSS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04978168?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04978168 being conducted?
This trial has 3 study locations across North Carolina, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04978168's enrollment target sits among peer trials
450 41st of 257 higher than 217 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00515060 · 450 participants
Psychophysical Studies of Cancer Therapy Pain
- NCT01257269 · 450 participants
Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
- NCT03047161 · 450 participants
Electrophysiology of Fetal Arrhythmia
- NCT03269630 · 450 participants
New Orleans Pulmonary Hypertension Biobank
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI